Cell cycle proteins as promising targets in cancer therapy
Crossref DOI link: https://doi.org/10.1038/nrc.2016.138
Published Online: 2017-01-27
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Otto, Tobias
Sicinski, Piotr
Text and Data Mining valid from 2017-01-27
Article History
First Online: 27 January 2017
Competing interests
: P.S. declares that he is a consultant for and receives research funding from Novartis.